Rio Tinto subsidiary Technological Resources has successfully challenged a decision by IP Australia to reject a patent application for a method of separating mined material, with a judge finding the claimed invention was not a collection of mere working directions as a delegate had found.
The ABC and Fairfax have lost their bid to file an amended defence in defamation proceedings brought by Chinese businessman Chau Chak Wing, several months after the Full Federal Court upheld a ruling striking out out the publishers’ truth defence.
An Uber Eats driver who was allegedly sacked for being ten minutes late is appealing the Fair Work Commission’s dismissal of her case.
Mining giant Fortescue Metals is seeking special leave from the High Court to appeal a ruling that granted native title to the Yinjibarndi people over a large section of land in the Pilbara region of Western Australia.
A sizeable group of employment lawyers from K&L Gates has parted ways with the US legal giant to set up its own specialist shop, shaking up the market for employment law services in Australia.
The Takeovers Panel has found that while a $2.5 million break fee included in a $470 million takeover offer lobbed during a bidding war for Western Australia power supplier Pacific Energy was not a “common market approach”, it was not anti-competitive or coercive.
Monster Energy has launched another Federal Court case against Vittoria Food & Beverage seeking to block the coffee maker from trading on the popularity of its Mother energy drink brand, and the beverage giant will have to convince the court that its brand is not so strong that confusion among consumers is not likely.
A former pre-insolvency advisor has been sentenced to four and half years in prison for siphoning money from defunct Telstra dealer Cap Coast Telecoms prior to it being voluntarily wound up.
Pfizer, maker of the blockbuster rheumatoid arthritis biologic Enbrel, has taken generic drug maker Sandoz to court for information on its Enbrel biosimilar, after winning a bid for preliminary discovery against Samsung Biopis to pursue a possible infringement case over the same drug.
Macquarie Bank has been hit with another lawsuit by former financial advisers who claim the bank underpaid them to the tune of $4.8 million by remunerating them solely in commission when they were entitled to a regular wage.